Biocept, Inc. (BIOC)

NASDAQ: BIOC · IEX Real-Time Price · USD
-0.16 (-6.90%)
At close: May 26, 2023, 4:00 PM
+0.06 (2.78%)
After-hours: May 26, 2023, 7:59 PM EDT

Total Valuation

Biocept has a market cap or net worth of $1.28 million. The enterprise value is $6.09 million.

Market Cap 1.28M
Enterprise Value 6.09M

Important Dates

The last earnings date was Wednesday, May 10, 2023, after market close.

Earnings Date May 10, 2023
Ex-Dividend Date n/a

Share Statistics

Biocept has 592,906 shares outstanding. The number of shares has increased by 4.57% in one year.

Shares Outstanding 592,906
Shares Change (YoY) +4.57%
Shares Change (QoQ) +3.27%
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 7.99%
Float 592,722

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.11
Forward PS 0.16
PB Ratio 0.53
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.54
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 4.77.

Current Ratio 2.07
Quick Ratio 1.80
Debt / Equity 4.77
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -208.30% and return on invested capital (ROIC) is -111.60%.

Return on Equity (ROE) -208.30%
Return on Assets (ROA) -83.90%
Return on Capital (ROIC) -111.60%
Revenue Per Employee $227,560
Profits Per Employee -$644,580
Employee Count 50
Asset Turnover 0.30
Inventory Turnover 10.77


Income Tax -125,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -94.86% in the last 52 weeks. The beta is 0.92, so Biocept's price volatility has been similar to the market average.

Beta (1Y) 0.92
52-Week Price Change -94.86%
50-Day Moving Average 8.27
200-Day Moving Average 18.20
Average Volume (30 Days) 132,156

Short Selling Information

The latest short interest is 235,195, so 39.67% of the outstanding shares have been sold short.

Short Interest 235,195
Short Previous Month 307,817
Short % of Shares Out 39.67%
Short % of Float 39.68%
Short Ratio (days to cover) 3.06

Income Statement

In the last 12 months, Biocept had revenue of $11.38 million and -$32.23 million in losses. Loss per share was -$56.70.

Revenue 11.38M
Gross Profit -9.76M
Operating Income -32.14M
Pretax Income -32.35M
Net Income -32.23M
EBITDA -30.06M
EBIT -32.05M
Loss Per Share -$56.70
Full Income Statement

Balance Sheet

The company has $6.77 million in cash and $11.58 million in debt, giving a net cash position of -$4.81 million or -$8.11 per share.

Cash & Cash Equivalents 6.77M
Total Debt 11.58M
Net Cash -4.81M
Net Cash Per Share -$8.11
Equity / Book Value 2.43M
Book Value Per Share 4.10
Working Capital 4.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.55 million and capital expenditures -$800,000, giving a free cash flow of -$19.35 million.

Operating Cash Flow -18.55M
Capital Expenditures -800,000
Free Cash Flow -19.35M
FCF Per Share -$32.95
Full Cash Flow Statement


Gross margin is -85.75%, with operating and profit margins of -282.48% and -283.26%.

Gross Margin -85.75%
Operating Margin -282.48%
Pretax Margin -284.36%
Profit Margin -283.26%
EBITDA Margin -264.23%
EBIT Margin -281.72%
FCF Margin -170.07%

Dividends & Yields

Biocept does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -2,516.56%
FCF Yield -1,511.00%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -4.57%
Shareholder Yield -4.57%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on May 17, 2023. It was a reverse split with a ratio of 1:30.

Last Split Date May 17, 2023
Split Type Reverse
Split Ratio 1:30